Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Acer therapeutics inc. crawled time : 14:01 save search
Acer Therapeutics Announces Topline Results from its Bioequivalence Trial of ACER-001 Compared to BUPHENYL® Under Fed Conditions
Published: 2021-02-11 (Crawled : 14:01) - globenewswire.com
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 1.47%
H: 10.6%
C: -3.86%
results trial topline
Acer Therapeutics Announces Full Enrollment of Pivotal Bioequivalence Trial of ACER-001 for Urea Cycle Disorders
Published: 2020-12-22 (Crawled : 14:01) - globenewswire.com
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 0.38%
H: 0.75%
C: -3.01%
urea trial enroll
Acer Therapeutics Announces Publication of Vascular Ehlers-Danlos Syndrome (vEDS) Patient Registry Data from Sweden
Published: 2020-12-17 (Crawled : 14:01) - globenewswire.com
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 0.0%
H: 8.61%
C: 0.41%
syndros
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.